Barbara-ann Guinn

May 31, 2024 | mdpi.com | Eithar Mohamed |Daniel Fletcher |Simon Hart |Barbara-ann Guinn

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Mar 28, 2024 | preprints.org | Daniel Fletcher |Simon Hart |Barbara-ann Guinn |Eithar Mohamed

Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 27 March 2024 / Approved: 28 March 2024 / Online: 28 March 2024 (09:40:50 CET) Mohamed, E.; Fletcher, D.; Hart, S.; Guinn, B. Can Tumour Antigens Provide Diagnostic Biomarkers for Early-Stage Non-small Cell Lung Cancer?. Preprints 2024, 2024031720. https://doi.org/10.20944/preprints202403.1720.v1 Mohamed, E.; Fletcher, D.; Hart, S.; Guinn, B.

Jun 2, 2023 | mdpi.com | Vanessa Morris |Daniel Fletcher |Barbara-ann Guinn |Hanya Ghazi

Abstract:Acute myeloid leukaemia (AML) is characterized by impaired myeloid differentiation resulting in an accumulation of immature blasts in the bone marrow and peripheral blood. Although AML can occur at any age, the incidence peaks at age 65. The pathobiology of AML also varies with age with associated differences in incidence, as well as the frequency of cytogenetic change and somatic mutations.